Csam Health Group AS
F:6Q1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/S
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Valuation Scenarios
If P/S returns to its 3-Year Average (2.1), the stock would be worth €3.67 (0% downside from current price).
| Scenario | P/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 2.1 | €3.67 |
0%
|
| 3-Year Average | 2.1 | €3.67 |
0%
|
| 5-Year Average | 2.1 | €3.67 |
0%
|
| Industry Average | 6 | €10.32 |
+181%
|
| Country Average | 2.1 | €3.59 |
-2%
|
Forward P/S
Today’s price vs future revenue
| Today's Market Cap | Revenue | Forward P/S | ||
|---|---|---|---|---|
|
€830.7m
|
/ |
Jul 2023
kr388.8m
|
= |
|
|
€830.7m
|
/ |
Dec 2023
kr37.8m
|
= |
|
|
€830.7m
|
/ |
Dec 2024
kr42.6m
|
= |
|
Forward P/S shows whether today’s P/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | P/S | P/E | ||||
|---|---|---|---|---|---|---|
| NO |
|
Csam Health Group AS
F:6Q1
|
830.7m EUR | 2.1 | -7.8 | |
| JP |
|
Medical Data Vision Co Ltd
TSE:3902
|
37.9T JPY | 9.7 | 227.5 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 5.4 | 53.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
25.9B USD | 8.1 | 28.5 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
14.1B AUD | 56.6 | 60 | |
| JP |
|
M3 Inc
TSE:2413
|
1T JPY | 3 | 20.8 | |
| SE |
|
Sectra AB
STO:SECT B
|
49.7B SEK | 21 | 91.8 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.8B USD | 4.3 | 42.2 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.5B USD | 7 | 18.7 | |
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
261.1B INR | 8.7 | 40.3 | |
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR | 11.9 | -328 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 1.1 |
| Median | 2.1 |
| 70th Percentile | 4 |
| Max | 77 165 |
Other Multiples
Csam Health Group AS
Glance View
CSAM Health Group AS is an e-health software company, which engages in the provision of clinical solutions for hospitals. The company is headquartered in Oslo, Oslo. The company went IPO on 2020-10-09. Its specialized software solutions are instrumental in the clinical care processes of healthcare providers and in enabling emergency responders to enhance public safety. The Company’s product portfolio includes solutions in public safety, connected healthcare, women and children's health, laboratory information management systems, medical imaging, medication management, and health analytics. CSAM is headquartered in Oslo, Norway with local offices in Sweden, Denmark, Finland, UK, Lithuania, Spain, New Zealand, the United States and the Philippines. CSAM delivers software and services to almost all hospitals in the Nordic region.
